---
title: "Laplace Interventional secures funding for clinical testing of transcatheter tricuspid valve technology"
date: "2023-08-02T09:21:41.000Z"
publishedDate: "2 août 2023"
summary: "Laplace Interventional, a medical device company developing a transcatheter tricuspid valve technology, has completed its first close on its Series B financing. The financing round was co-led by ShangBay Capital along with Features Capital, including participation from Engage Venture Partners, JWC Ventures as well as a global strategic investor."
importance: ""
sourceUrl: "https://cardiovascularnews.com/laplace-interventional-series-b-financing/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2023-08-02-laplace-interventional-secures-funding-for-clinical-testing-of-transcatheter-tricuspid-valve-technology"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/08/LaplaceInterventional_CMYK_full_colour_Logo.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/laplace-interventional-series-b-financing/"
---

![Laplace Interventional secures funding for clinical testing of transcatheter tricuspid valve technology](https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/08/LaplaceInterventional_CMYK_full_colour_Logo.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/laplace-interventional-series-b-financing/*

## L’essentiel

Laplace Interventional, a medical device company developing a transcatheter tricuspid valve technology, has completed its first close on its Series B financing. The financing round was co-led by ShangBay Capital along with Features Capital, including participation from Engage Venture Partners, JWC Ventures as well as a global strategic investor.

## Lien source

https://cardiovascularnews.com/laplace-interventional-series-b-financing/
